Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety and Feasibility Trial of Adipose-Derived Regenerative Cells in the Treatment of Chronic Myocardial Ischemia (ATHENA)

This study has been completed.
Information provided by (Responsible Party):
Cytori Therapeutics Identifier:
First received: March 14, 2012
Last updated: October 26, 2016
Last verified: October 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2016
  Primary Completion Date: August 2015 (Final data collection date for primary outcome measure)